Cancer Imaging

Article	Citations
Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings	140
How to develop a meaningful radiomic signature for clinical use in oncologic patients	108
18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma	45
Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation	39
Radiomics for glioblastoma survival analysis in pre-operative MRI: exploring feature robustness, class boundaries, and machine learning techniques	38
Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study	38
Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer	34
What scans we will read: imaging instrumentation trends in clinical oncology	32
A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy	32
MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins	30
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy	29
Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer	29
Evaluation of CT-based radiomics signature and nomogram as prognostic markers in patients with laryngeal squamous cell carcinoma	28
Predicting microvascular invasion in hepatocellular carcinoma: a deep learning model validated across hospitals	28
Robustness of magnetic resonance radiomic features to pixel size resampling and interpolation in patients with cervical cancer	27
Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations	27
The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI	26
MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma	26
A CT-based radiomics nomogram for prediction of lung adenocarcinomas and granulomatous lesions in patient with solitary sub-centimeter solid nodules	25
Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer	25
CT-based radiomics features in the prediction of thyroid cartilage invasion from laryngeal and hypopharyngeal squamous cell carcinoma	24
Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features	23
Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study	23
A CT-based radiomics nomogram for distinguishing between benign and malignant bone tumours	22
Diagnostic value of 18F-FDG PET/MRI for staging in patients with endometrial cancer	21

Value of 18F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers	21
MRI-based radiomics to predict lipomatous soft tissue tumors malignancy: a pilot study	21
Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact	21
Network-level functional connectivity alterations in chemotherapy treated breast cancer patients: a longitudinal resting state functional MRI study	21
Tumor stiffness measured by shear wave elastography correlates with tumor hypoxia as well as histologic biomarkers in breast cancer	20
Multi-view secondary input collaborative deep learning for lung nodule 3D segmentation	20
Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer	20
High resolution MRI-based radiomic nomogram in predicting perineural invasion in rectal cancer	19
Usefulness of 18F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature	18
A prospective analysis of the diagnostic accuracy of 3 T MRI, CT and endoscopic ultrasound for preoperative T staging of potentially resectable esophageal cancer	18
The application of texture quantification in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges	18
Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study	18
Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC)	18
Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer	17
Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy	16
Diagnostic efficiency of whole-body 18F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer	16
Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as g	16
Dynamic contrast-enhanced MRI radiomics nomogram for predicting axillary lymph node metastasis in breast cancer	15
Preoperative assessment of lymph node metastasis in Colon Cancer patients using machine learning: a pilot study	15
Extracellular volume fraction measurement correlates with lymphocyte abundance in thymic epithelial tumors	14
Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients	14
CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas	14
CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma	14
Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach	13
Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma	13
MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy	13
Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study	13
Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors	12
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET	12
Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study	12
Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing 18F-FDG-PET/CT: a comparison with serologic markers of tumor burden and inflammation	12
Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography	12
Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography	12
Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC)	12
PET/CT variants and pitfalls in malignant melanoma	11
PET/MR fusion texture analysis for the clinical outcome prediction in soft-tissue sarcoma	11
“Real-world” radiomics from multi-vendor MRI: an original retrospective study on the prediction of nodal status and disease survival in breast cancer, as an exemplar to promote discussion of the wider	11
Gallbladder carcinoma: an initial clinical experience of reduced field-of-view diffusion-weighted MRI	11
The role of resting-state functional MRI for clinical preoperative language mapping	11
Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade	11
The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT	11
Magnetic Resonance Elastography reveals effects of anti-angiogenic glioblastoma treatment on tumor stiffness and captures progression in an orthotopic mouse model	11
Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma	11
Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?	10
Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT	10
Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast	10
Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study	10
Automatic segmentation of head and neck primary tumors on MRI using a multi-view CNN	10
Nomograms based on SUVmax of 18F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma	10
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise	10

FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma	10
FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: a case series and literature review	10
Magnetic resonance diffusion kurtosis imaging in differential diagnosis of benign and malignant renal tumors	10
Clustering subtypes of breast cancer by combining immunohistochemistry profiles and metabolism characteristics measured using FDG PET/CT	9
Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC	9
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy	9
Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer	9
Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments	9
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib	9
Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review	9
The prognostic value of 18F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients	8
Native T1 mapping for differentiating the histopathologic type, grade, and stage of rectal adenocarcinoma: a pilot study	8
Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma	8
Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging	8
Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy	8
The current status and future prospects for molecular imaging-guided precision surgery	8
Utility of the deep learning technique for the diagnosis of orbital invasion on CT in patients with a nasal or sinonasal tumor	8
Combinative evaluation of primary tumor and lymph nodes to predict pelvic lymphatic metastasis in cervical cancer: an integrated PET-IVIM MRI study	8
Application of diffusion kurtosis tensor MR imaging in characterization of renal cell carcinomas with different pathological types and grades	8
The value of contrast‐enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer	8
Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatment	8
Texture analysis of iodine maps and conventional images for k-nearest neighbor classification of benign and metastatic lung nodules	7
Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics	7
Associations between dynamic-contrast enhanced MRI and tumor infiltrating lymphocytes and tumor-stroma ratio in head and neck squamous cell cancer	7
Post-PRRT scans: which scans to make and what to look for	7
Whole-body diffusion-weighted MRI of normal lymph nodes: prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort	7
Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study	7
Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy	7
Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery?	7
Development and validation of a CT-texture analysis nomogram for preoperatively differentiating thymic epithelial tumor histologic subtypes	7
Magnetic resonance imaging of pure ovarian dysgerminoma: a series of eight cases	7
MRI-guided percutaneous thermoablation in combination with hepatic resection as parenchyma-sparing approach in patients with primary and secondary hepatic malignancies: single center long-term experie	7
Imaging of head and neck mucosa-associated lymphoid tissue lymphoma (MALToma)	7
The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy	7
What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis	7
Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma	7
Differentiation of renal angiomyolipoma without visible fat from small clear cell renal cell carcinoma by using specific region of interest on contrast-enhanced CT: a new combination of quantitative t	6
Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to 18F-FDG PET/CT	6
Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer	6
Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACE	6
Iodine-related attenuation in contrast-enhanced dual-energy computed tomography in small-sized solid-type lung cancers is associated with the postoperative prognosis	6
Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification	6
Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma	6
Investigating the value of arterial spin labeling and intravoxel incoherent motion imaging on diagnosing nasopharyngeal carcinoma in T1 stage	6
Development and definition of a simplified scoring system in patients with multiple myeloma undergoing stem cells transplantation on standard computed tomography: myeloma spine and bone damage score (	6
Radiology reporting in oncology—oncologists’ perspective	6
Determining the elastography strain ratio cut off value for differentiating benign from malignant breast lesions: systematic review and meta-analysis	6
Predicting prognosis of nasopharyngeal carcinoma based on deep learning: peritumoral region should be valued	6
High resolution diffusion-weighted imaging with readout segmentation of long variable echo-trains for determining myometrial invasion in endometrial carcinoma	6
Are radiomics features universally applicable to different organs?	6
Primary disease sites and patterns of spread in cases of neurolymphomatosis in the orbit associated with lymphoma	6
Detection of prostate cancer using diffusion-relaxation correlation spectrum imaging with support vector machine model – a feasibility study	6
Clinical efficacy and prognostic factors of CT-guided 125I brachytherapy for the palliative treatment of retroperitoneal metastatic lymph nodes	6
Tumor stiffness measured by 3D magnetic resonance elastography can help predict the aggressiveness of endometrial carcinoma: preliminary findings	6
Integrated slice-specific dynamic shimming diffusion weighted imaging (DWI) for rectal Cancer detection and characterization	6
Tumor conspicuity significantly correlates with postoperative recurrence in patients with pancreatic cancer: a retrospective observational study	5
Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?	5
Ultrasound features of medullary thyroid cancer as predictors of biological behavior	5
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI	5
Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors	5
CT texture analysis and node-RADS CT score of mediastinal lymph nodes - diagnostic performance in lung cancer patients	5
Rectal cancer: a methodological approach to matching PET/MRI to histopathology	5
Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives	5
The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer	5
Preoperative tumor size measurement in breast cancer patients: which threshold is appropriate on computer-aided detection for breast MRI?	5
Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms	5
MR imaging features of pancreatic schwannoma: a Chinese case series and a systematic review of 25 cases	5
The comparative study of color doppler flow imaging, superb microvascular imaging, contrast-enhanced ultrasound micro flow imaging in blood flow analysis of solid renal mass	5
Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance	5
Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features	5
TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience	5
Predictive CT features for the diagnosis of primary pulmonary mucoepidermoid carcinoma: comparison with squamous cell carcinomas and adenocarcinomas	5
Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE)	5
Inter-observer agreement of baseline whole body MRI in multiple myeloma	5
Multi-tracer and multiparametric PET imaging to detect the IDH mutation in glioma: a preclinical translational in vitro, in vivo, and ex vivo study	5
A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer	5
Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy: a systematic review and meta-analysis	5
A comparative study of methods for determining Intravoxel incoherent motion parameters in cervix cancer	4
Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study	4
Deep learning for semi-automated unidirectional measurement of lung tumor size in CT	4

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors	4
Arterial spin labeling and diffusion-weighted imaging for identification of retropharyngeal lymph nodes in patients with nasopharyngeal carcinoma	4
Prognostic value of 18F-FDG PET /CT metabolic parameters in patients with locally advanced pancreatic Cancer treated with stereotactic body radiation therapy	4
Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review	4
DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases	4
Primary hepatic malignant vascular tumors: a follow-up study of imaging characteristics and clinicopathological features	4
Novel applications of molecular imaging to guide breast cancer therapy	4
Multiparametric detection and outcome prediction of pancreatic cancer involving dual-energy CT, diffusion-weighted MRI, and radiomics	4
Quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging to predict lymphovascular invasion and survival outcome in breast cancer	4
Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography – the next dimension of diagnosis	4
Contrast enhanced mammography: focus on frequently encountered benign and malignant diagnoses	4
Endometrial carcinoma: use of tracer kinetic modeling of dynamic contrast-enhanced MRI for preoperative risk assessment	4
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy	4
CT patterns and serial CT Changes in lung Cancer patients post stereotactic body radiotherapy (SBRT)	4
Improving the diagnosis of radiation necrosis after stereotactic radiosurgery to intracranial metastases with conventional MRI features: a case series	4
Will ultra-extended field-of-view scanners be an expensive folly or the next clinical standard for PET/CT?	4
Diffusion-weighted magnetic resonance imaging of primary cervical cancer in the detection of sub-centimetre metastatic lymph nodes	4
Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?	4
Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?	3
Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy	3
Normal size of benign upper neck nodes on MRI: parotid, submandibular, occipital, facial, retroauricular and level IIb nodal groups	3
Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy	3
Prostate MRI using a rigid two-channel phased-array endorectal coil: comparison with phased array coil acquisition at 3 T	3
Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, 18F-FDG PET/MRI and CA 19–9	3
Sarcomatoid renal cell carcinoma: MRI features and their association with survival	3
Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors	3
Sononeoperfusion: a new therapeutic effect to enhance tumour blood perfusion using diagnostic ultrasound and microbubbles	3
Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients	3
Free-breathing radial 3D fat-suppressed T1-weighted gradient echo (r-VIBE) sequence for assessment of pulmonary lesions: a prospective comparison of CT and MRI	3
A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables	3
Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study	3
Deep learning based identification of bone scintigraphies containing metastatic bone disease foci	3
The value of bone marrow, liver, and spleen imaging in diagnosis, prognostication, and follow-up monitoring of myeloproliferative neoplasms: a systematic review	3
Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma	3
Validation of the ALBI-TAE model and comparison of seven scoring systems for predicting survival outcome in patients with intermediate‐stage hepatocellular carcinoma undergoing chemoembolization	3
Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis?	3
Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study	3
Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma	3
The feasibility of 18F-FDG PET/CT for predicting pathologic risk status in early-stage uterine cervical squamous cancer	3